版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
煩惱有何懼怕,既然躲不掉,就調(diào)好心態(tài)與它共存。心向陽(yáng)光,何懼風(fēng)霜。
茫茫人海你我相遇就是緣分,歡迎下載!EpidemiologyofInsulinResistance,DiabetesMellitus,andCoronaryHeartDisease
AdaptedfromWorldHealthOrganization.Definition,DiagnosisandClassificationofDiabetesMellitus
anditsComplications.Geneva:WorldHealthOrganization:1999:52.CriteriafortheDiagnosisofDiabetesMellitusandHyperglycemia
PlasmaGlucoseConcentration>7.0(>126)
>6.1(>110)to<7.0(<126)2-HourPost
GlucoseLoadFasting
GlucoseDiabetesMellitusImpairedGlucoseToleranceImpairedFastingGlucose>11.1(>200)>7.8(>140)to
<11.1(<200)
Valuesaremmol/L(mg/dl)DevelopedDevelopingPercentKingHetal.DiabetesCare1998;21:1414-1431.World1995PrevalenceofDiabetesinAdultPopulation
(Aged>20years)byYearandRegion20002025HospitalizationCostsforChronicComplicationsofDiabetesintheUSAmericanDiabetesAssociation.EconomicConsequencesofDiabetesMellitus
intheUSin1997.Alexandria,VA:AmericanDiabetesAssociation,1998:1-14.Totalcosts12billionUS$CVDaccountsfor64%oftotalcostsOthersOphthalmic
diseaseCardiovascular
diseaseRenal
diseaseNeurologic
diseasePeripheral
vascular
diseaseAnnualCHDDeathsper1000PersonsKannelWB,McGeeDL.JAMA1979;241:2035-2038.FraminghamStudy:DMandCHDMortality
20-YearFollow-up178174MenWomenDMNon-DMIschemic
heart
disease%ofDeathsGeissLSetal.In:DiabetesinAmerica.2nded.1995;chap11.MortalityinPeoplewithDiabetes
CausesofDeathOther
heart
diseaseDiabetesCancerStrokeInfectionOtherMortalityper1000
person-years**Age-adjustedAdaptedfromGuKetal.DiabetesCare1998;21:1138-1145.MortalityDuetoHeartDiseaseinMenandWomenwithorwithoutDiabetes(US)29.919.2MenWomenDiabetesNoDiabetesAllheartdiseaseIschemicheartdiseaseMenWomen11.56.323.07.111.03.6NondiabetesDiabetes*Definedin1971-1975,followedupthrough1982-1984.
**Definedin1982-1984,followedupthrough1992-1993.GuKetal.JAMA1999;281:1291-1297.TrendsinMortalityRatesforIschemicHeartDiseaseinNHANESSubjectswithandwithoutDiabetes*17.06.8-16.6%+10.7%Men,cohort1*Men,cohort2**Women,cohort1*Women,cohort2**-43.8%-20.4%14.27.67.44.22.41.9(P=0.46)(P=0.76)(P<0.001)(P=0.12)Rateper1000person-yearsWOMENMENSurvivalPost-MIinDiabeticandNondiabeticMenandWomen:MinnesotaHeartSurveyAdaptedfromSprafkaJMetal.DiabetesCare1991;14:537-543.1008060400Survival(%)MonthsPost-MINodiabetesn=228n=1628MonthsPost-MISurvival(%)0204060Diabetes100806040080020406080DiabetesNodiabetesn=156n=568WOMENMENCardiovascularMortalityinPeople
withDiabetes%ofDeaths(CrudeRate)AdaptedfromMiettinenHetal.DiabetesCare.1998;21:69-75.DiabetesNoDiabetes28.622.110.911.9DiabetesNoDiabetes15.49.622.79.09.14.211.12.828d–1yHospitalization–28dOutofHospital9、人的價(jià)值,在招收誘惑的一瞬間被決定。2023/2/32023/2/3Friday,February3,202310、低頭要有勇氣,抬頭要有低氣。2023/2/32023/2/32023/2/32/3/20234:55:34PM11、人總是珍惜為得到。2023/2/32023/2/32023/2/3Feb-2303-Feb-2312、人亂于心,不寬余請(qǐng)。2023/2/32023/2/32023/2/3Friday,February3,202313、生氣是拿別人做錯(cuò)的事來(lái)懲罰自己。2023/2/32023/2/32023/2/32023/2/32/3/202314、抱最大的希望,作最大的努力。03二月20232023/2/32023/2/32023/2/315、一個(gè)人炫耀什么,說(shuō)明他內(nèi)心缺少什么。。二月232023/2/32023/2/32023/2/32/3/202316、業(yè)余生活要有意義,不要越軌。2023/2/32023/2/303February202317、一個(gè)人即使已登上頂峰,也仍要自強(qiáng)不息。2023/2/32023/2/32023/2/32023/2/3InfluenceofMultipleRiskFactors*onCVDDeathRatesinDiabeticandNondiabeticMen:MRFITScreeneesNoneOneonlyAge-adjustedCVDdeathrateper10,000person-years*Serumcholesterol>200mg/dl,smoking,SBP>120mmHgStamlerJetal.DiabetesCare1993;16:434-444AllthreeNodiabetesDiabetesTwoonlyPutativeMechanismforIncreasedAtherosclerosisinType2DiabetesBLACKBOXDyslipidemiaHypertensionHyperinsulinemia/insulinresistanceHemostaticabnormalitiesHyperglycemiaAGEproteinsOxidativestressAGE=advancedglycationendproductsAdaptedfromBiermanEL.Arterioscler
Thromb1992;12:647-656.
+=moderatelyincreasedcomparedwithnondiabeticpopulation++=markedlyincreasedcomparedwithnondiabeticpopulation–=notdifferentcomparedwithnondiabeticpopulationPrevalenceofCardiovascularRiskFactorsinDiabeticSubjectsRelativetoNondiabeticsType1Dyslipidemia
Hypertriglyceridemia
LowHDL
Small,denseLDL
IncreasedapoBHypertensionHyperinsulinemia/insulinresistanceCentralobesityFamilyhistoryofatherosclerosisCigarettesmokingAdaptedfromChaitA,BiermanEL.In:Joslin’sDiabetesMellitus.Philadelphia:Lea&Febiger,1994:648-664.Type2RiskFactor
+–––+––––
+++++++++++++++–DifferencesinHDLCholesterolandLDLSizebyDiabeticStatusinWomenandMenHowardBVetal.DiabetesCare1998;21:1258-1265.0-2-4-6-8DifferencesbetweenparticipantswithandwithoutdiabetesHDLCholesterolLDLSize?0-2-4-6-8mg/dLWomenMenWomenMenStrategiesforReductionofDiabeticComplicationsMicrovascularcomplications
-Aggressivescreening
-ImprovedmetaboliccontrolMacrovascularcomplications
-Improvedglycemiccontrol(positivebutminor)
-Preventionoftype2diabetes
-AggressivetreatmentofestablishedCVRFin
diabeticandpossiblyprediabeticsubjects
-DiabeticagentsthatimprovecardiovascularriskIncidenceRatesofMIandMicrovascularEndpointsbyMeanSystolicBloodPressure:UKPDS110120130140150160170Incidenceper1000Person
Years(%)AdlerAIetal.BMJ2000;321:412-419.UpdatedMeanSystolicBloodPressure(mmHg)Adjustedforage,sex,andethnicgroupMyocardialInfarctionMicrovascularEndpointsIncidenceRatesofMIandMicrovascularEndpointsbyMeanHemoglobin
A1c:UKPDS567891011Incidenceper1000Person
Years(%)StrattonIMetal.BMJ2000;321:405-412.UpdatedMeanHemoglobinA1cConcentration(%)Adjustedforage,sex,andethnicgroupMyocardialInfarctionMicrovascularEndpointsPlasmaInsulinandTriglyceridesPredictIschemicHeartDisease:QuebecCardiovascularStudyDespresJPetal.NEnglJMed1996;334:952-957.OddsRatio<1212-15>15F-Insulin(U/ml)4.6p=0.005>150mg/dl<150mg/dlTriglycerides1.01.55.3p=0.001P<0.0016.75.4P=0.002PlasmaInsulinandApolipoproteinBPredictIschemicHeartDisease:QuebecCardiovascularStudyDespresJPetal.NEnglJMed1996;334:952-957.OddsRatio<1212-15>15F-Insulin(U/ml)3.0p=0.04>119mg/dl<119mg/dlApolipoproteinB1.01.53.2p<0.00111.09.7P<0.001p=0.04LDLParticleSizeandApolipoproteinBPredictIschemicHeartDisease:QuebecCardiovascularStudyLamarcheBetal.Circulation1997;95:69-75.>25.64<25.64LDLPeakParticleDiameter(nm)1.01.06.2(p<0.001)ApoB>120mg/dl2.0<120mg/dlBaselineAnthropometricVariablesandCardiovascularRiskFactorsinSubjectswithNormalGlucoseToleranceatBaselineAccordingtoConversionStatusat8-YearFollow-up:SanAntonioHeartStudyBMI(kg/m2)Centrality*TG(mmol)HDLC(mmol)SBP(mmHg)Fastingglucose(mmol)Fastinginsulin(pmol)HaffnerSMetal.JAMA1990;263:2893-2898.28.2+1.11.38+0.091.83+0.121.14+0.07116.8+3.05.28+0.1157+2727.2+0.21.16+0.21.26+0.101.28+0.02108.8+0.85.00+0.0281+5.472.472.006.045.004.032.006ConversionStatusatFollow-upDiabetes(n=18)Normal(n=490)P*Ratioofsubscapulartotricepsskinfolds“TickingClock”HypothesisWHO.Diabetologia1985;28:615-640;HaffnerSMetal.JAMA1990;263:2893-2898.ForMicrovascularcomplicationsMacrovascularcomplicationsThe“clockstartsticking”Atonsetofhyperglycemia
BeforethediagnosisofhyperglycemiaHemoglobinA1FastingGlucoseThe7-YearAge-AdjustedIncidenceofCHDMortalityandAllCHDEvents:East-WestStudyLehtoSetal.Diabetes1997;46:1354-1359.403020100%IncidenceP-glucose(mmol/L)<9.69.6-13.4>13.4403020100%IncidenceCHDMortalityAllCHDEventsCHDMortalityAllCHDEventsHbA1(%)<8.98.9-10.7>10.7StepwiseSelectionofRiskFactors*in2693WhitePatientswithType2DiabeteswithDependentVariableasTimetoFirstEvent:UKPDS
VariableLow-DensityLipoproteinCholesterolHigh-DensityLipoproteinCholesterolHemoglobinA1cSystolicBloodPressureSmokingPValue<0.00010.00010.00220.00650.056CoronaryArteryDisease(n=280)PositioninModelFirstSecondThirdFourthFifth*Adjustedforageandsex.TurnerRCetal.BMJ1998;316:823-828.CriteriaforAcceptingCardiovascularRiskFactorManagementasSimilarinDiabeticandCHDSubjectsTheriskofvasculardiseaseissimilarindiabeticsubjectswithoutpre-existingvasculardiseaseasinnondiabeticsubjectswithvasculardiseaseGlycemiaalonewillnotcompletelyeliminatetheexcessofCHDriskindiabeticsubjectsLipidinterventionstoreduceCHDcanbeequallyeffectiveindiabeticandnondiabeticsubjectsIncidenceofFatalorNonfatalMIDuringa7-YearFollow-upinRelationtoHistoryofMIinNondiabeticvsDiabeticSubjects:East-WestStudyIncidenceDuringFollow-up(%)(n=69)NondiabeticswithpriorMINondiabeticswithnopriorMIDiabeticswithpriorMIDiabeticswithnopriorMI18.8HaffnerSMetal.NEnglJMed1998;339:229-234.(n=1304)(n=169)(n=890)3.00.57.83.23.545.020.2Eventsper
100person-yr:P<0.001p<0.001IncidenceofFatalorNonfatalStrokeDuringa
7-YearFollow-upinRelationtoHistoryofMIinNondiabeticvsDiabeticSubjects:East-WestStudyIncidenceDuringFollow-up(%)(n=69)NondiabeticswithpriorMINondiabeticswithnopriorMIDiabeticswithpriorMIDiabeticswithnopriorMI7.2HaffnerSMetal.NEngl
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024年日語(yǔ)外貿(mào)業(yè)務(wù)員勞動(dòng)協(xié)議
- 2024年電氣工程服務(wù)協(xié)議詳細(xì)模板
- 2023-2024學(xué)年中原名校高考數(shù)學(xué)試題仿真卷:數(shù)學(xué)試題試卷
- 2024年創(chuàng)意動(dòng)畫(huà)廣告制作協(xié)議示例
- 2024專(zhuān)業(yè)護(hù)士聘用協(xié)議細(xì)則
- 2024年度黨組織結(jié)對(duì)共建協(xié)議
- DB11∕T 1721-2020 水生生物調(diào)查技術(shù)規(guī)范
- 2024精制陶瓷購(gòu)銷(xiāo)協(xié)議樣本
- 二手車(chē)銷(xiāo)售協(xié)議范本(個(gè)性化)
- 2024年煤礦作業(yè)自卸運(yùn)輸車(chē)銷(xiāo)售協(xié)議
- 供應(yīng)商調(diào)查表格式
- 民警職務(wù)晉升考察材料范文四篇
- 公交車(chē)站突發(fā)事件處置方案
- 中石化定額章節(jié)官方解析交流148篇答疑
- 腫瘤科疑難病例討論發(fā)熱
- 人民醫(yī)院胸外科臨床技術(shù)操作規(guī)范2023版
- 技術(shù)授權(quán)協(xié)議書(shū)(模板)
- 人教部編版四年級(jí)語(yǔ)文上冊(cè)古詩(shī)詞日積月累默寫(xiě)模板
- 地下水處理技術(shù)方案及報(bào)價(jià)
- 高考語(yǔ)文復(fù)習(xí)-詩(shī)歌選擇題解題技巧 教案
- 水泥砂漿砌石體單元評(píng)定表
評(píng)論
0/150
提交評(píng)論